Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis: Clinical characteristics and disability progression in Moroccan children.
An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial.
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.
Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.
Clinical profile and short-term outcomes of optic neuritis patients in India.
[Diagnosis and treatment of pelvic disorders in patients with multiple sclerosis].
Management of bladder dysfunction in patients with multiple sclerosis.
Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models.
The new therapeutic landscape in multiple sclerosis: exciting times and new perspectives.
Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice.
Atorvastatin: Multiple Sclerosis.
Treatment patterns in multiple sclerosis: administrative claims analysis over 10 years.
Novel Marmoset (Callithrix jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization.
Paracaspase MALT1 Deficiency Protects Mice from Autoimmune-Mediated Demyelination.
Diffusion tensor imaging in pediatric transverse myelitis: A case study.
Assessing possible selection bias in a national voluntary MS longitudinal study in Australia.
Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis.
Concise review: mesenchymal stem cells and translational medicine: emerging issues.
Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Role of intestinal microbiota in the development of multiple sclerosis.
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.
Treadmill training in multiple sclerosis: can body weight support or robot assistance provide added value? A systematic review.

Pages